Activated expression of growth regulating peptides is a hallmark of neoplasia. The conspicuous induction of transforming growth factor-alpha (TCFalpha) in a wide array of human and animal tumors, as well as in transformed cell lines, is a case in point. A member of the EGF receptor ligand family, TGFalpha is a potent mitogen for epithelial and mesenchymal cells. It also regulates cell differentiation and migration, and it has been implicated in angiogenesis, wound healing and liver regeneration. To explore the pathological consequences of activated TGFalpha expression we created lines of transgenic mice that overexpress the growth factor in multiple tissues. A significant consequence was the development of breast cancer with high incidence in postlactational females. Targeted expression of TGFalpha in the lactating mammary gland under the control of the whey acidic protein (WAP) promoter produced transplantable carcinomas, one of which metastasized to lung. In multiparous females, focal tumors were found in association with large number os hyperplastic alveolar (HANs) the origin of which is suggested by our observation that TGFalpha blocked, or at least partially inhibited, the normal destruction of mammary glands at the end of lactation (involution). IN light of these various results, we hypothesize that not-regressed glands constitute preneoplastic lesions. Cells in a fraction of these eventually form tumors as a result of additional genetic events. We propose to further examine the mechanisms by which TGFalpha induces breast cancer in these unique models.
Our Specific Aims are to: (1) characterize the molecular characterize the molecular phenotypes of breast tumors induced by deregulated expression of TGFalpha; 2) investigate the mechanism(s) by which expression the WAP- TGFalpha transgene initiates the development of breast cancer; and 3) explore the possibility that TGFalpha transgenic mice provide a model with which to study neoplastic progression in breast.
In Aim I, we will correlate patterns and levels of expression of the different transgenes, and compare these results with various characteristics of the resulting tumors, focussing in part on how neoplastic induction by a polypeptide growth factor influences steroid hormone responsiveness of resulting tumors. Additionally, we will look for amplification and/or activated expression of particular candidate genes (e.g. EGF-R and new), and we will develop new transgenic models for other members of the ligand/receptor signalling family, In Aim II, we will further explore effects of TGFalpha on the development on the development and regression of mammary glands with a particular focus on the possibility that it blocks the normal apoptotic events. We will also examine the activity of a non-cleavable form of proTGFalpha.
In Aim III, we will further characterize the TGFalpha-induced HANs to determine whether they provide a model of neoplastic progression, and we will utilize a retroviral tagging approach to identify genes that might cooperate with TGFalpha breast tumorigenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA061896-02
Application #
2102748
Study Section
Pathology B Study Section (PTHB)
Project Start
1994-08-01
Project End
1999-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Sternlicht, Mark D; Sunnarborg, Susan W (2008) The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. J Mammary Gland Biol Neoplasia 13:181-94
Hsieh, Minnie; Lee, Daekee; Panigone, Sara et al. (2007) Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol 27:1914-24
Sternlicht, Mark D; Sunnarborg, Susan W; Kouros-Mehr, Hosein et al. (2005) Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132:3923-33
Jackson, Leslie F; Qiu, Ting Hu; Sunnarborg, Susan W et al. (2003) Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22:2704-16
Troyer, K L; Lee, D C (2001) Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia 6:7-21
Schroeder, J A; Troyer, K L; Lee, D C (2000) Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Oncogene 19:3193-9
Luetteke, N C; Qiu, T H; Fenton, S E et al. (1999) Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126:2739-50
Schroeder, J A; Lee, D C (1998) Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ 9:451-64
Schroeder, J A; Lee, D C (1997) Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia. J Mammary Gland Biol Neoplasia 2:119-29
Lee, D C; Fenton, S E; Berkowitz, E A et al. (1995) Transforming growth factor alpha: expression, regulation, and biological activities. Pharmacol Rev 47:51-85

Showing the most recent 10 out of 11 publications